Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma

Fig. 2

Prognostic value of risk score from m6A RNA methylation modulators expression in PAAD patients. A Cox univariate analysis of m6A RNA methylation modulators. B and C Selection of genes by LASSO Cox regression. D Nomogram predicting 1-, 2-, and 3-year survival of patients with PAAD based on the expression of selected m6A RNA methylation modulators. The top row shows the point value for each variable, rows 2–6 indicate the expression of selected m6A RNA methylation modulators, the sum of these values is located on the Total Points axis, and the line drawn downward to the survival axes is used to determine the likelihood of 1-, 2- or 3-year survival. Calibration of nomograms predicting. Calibration of nomograms predicting E 1-year, F 2-year, and G 3-year survival

Back to article page